A Brief Report of Durvalumab With or Without Tremelimumab in Combination With Chemotherapy as First-Line Therapy for Metastatic Non-Small-Cell Lung Cancer: Outcomes by Tumor PD-L1 Expression in the Phase 3 POSEIDON Study
Titel:
A Brief Report of Durvalumab With or Without Tremelimumab in Combination With Chemotherapy as First-Line Therapy for Metastatic Non-Small-Cell Lung Cancer: Outcomes by Tumor PD-L1 Expression in the Phase 3 POSEIDON Study
Auteur:
Garon, Edward B. Cho, Byoung Chul Luft, Alexander Alatorre-Alexander, Jorge Geater, Sarayut Lucien Trukhin, Dmytro Kim, Sang-We Ursol, Grygorii Hussein, Maen Lim, Farah Louise Yang, Cheng-Ta Araujo, Luiz Henrique Saito, Haruhiro Reinmuth, Niels Kohlmann, Milena Lowery, Caitlin Mann, Helen Peters, Solange Mok, Tony S. Johnson, Melissa L.